Research

Bjoern Bauer honored as a 2023-24 University Research Professor

of
Bauer's research is focused on understanding blood-brain barrier function in health and disease including epilepsy, Alzheimer’s disease, and brain cancer. Jeremy Blackburn | UK Research Communications
Bjoern Bauer, Ph.D., professor in the department of pharmaceutical sciences, is one of 16 University Research Professors for 2023-24. Jeremy Blackburn | UK Research Communications
Bauer recently obtained a College of Pharmacy Team Science Pilot Award where the goal is to establish a bench-to-bedside pipeline so research can translate into the clinic for the benefit of patients. Jeremy Blackburn | UK Research Communications

LEXINGTON, Ky. (June 27, 2023) — Bjoern Bauer, Ph.D., professor in the Department of Pharmaceutical Sciences in the University of Kentucky College of Pharmacy, is one of 16 University Research Professors for 2023-24. The University Research Professorships honor faculty members who have demonstrated excellence that addresses scientific, social, cultural and economic challenges in our region and around the world. 

College leadership develop criteria for excellence within their area of expertise and then nominate faculty who excelled at these criteria. Each University Research Professor receives a one-year award of $10,000. 

“It is a great honor to receive this award and a humbling experience because it is based on a nomination by my colleagues and college leadership,” said Bauer. “I would have never expected to receive such an award considering the fantastic researchers, who received it in the past that I look up to.”

Bauer’s research is focused on understanding blood-brain barrier function in health and diseases including epilepsy, Alzheimer’s disease and brain cancer. The goal of his research is to find therapeutic targets to repair barrier dysfunction in these diseases.

Throughout the last 18 years, Bauer has worked on identifying the signaling pathways through which epileptic seizures lead to barrier dysfunction. He and other researchers have now identified several targets that have FDA-approved drugs for and have patented the repurposing of these drugs for their use to repair barrier dysfunction. Bauer and others recently obtained a College of Pharmacy Team Science Pilot Award where the goal is to establish a bench-to-bedside pipeline so they can translate their research into the clinic for the benefit of patients.

“I thank my long-term collaborator and wife Anika Hartz and our three daughters, who patiently accept all the science talk in our house. I also thank my current and past team members, my wonderful past and current collaborators I have had over the years both here at UK and outside UK, and all of the great mentors I have had throughout my career,” said Bauer. “I love coming to work every day and that is in great part due to all the people who I have worked with along the way.”

As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.   

In 2022, UK was ranked by Forbes as one of the “Best Employers for New Grads” and named a “Diversity Champion” by INSIGHT into Diversity, a testament to our commitment to advance Kentucky and create a community of belonging for everyone. While our mission looks different in many ways than it did in 1865, the vision of service to our Commonwealth and the world remains the same. We are the University for Kentucky.